Literature DB >> 21558614

Psychological status is associated with health related quality of life in patients with rheumatoid arthritis.

Kemal Nas1, Aysegul Jale Sarac, Ali Gur, Remzi Cevik, Zuhal Altay, Akin Erdal, Yuksel Ersoy, Arzu Kaya, Ibrahim Tekeoglu, Mahir Ugur, Bekir Durmus, Ozge Ardicoglu, Kazim Senel, Ozlem Baysal, Ayhan Kamanli, Saliha Karatay, Kadir Yildirim, Salih Ozgocmen.   

Abstract

OBJECTIVE: Rheumatoid arthritis (RA) is a chronic and disabling disease frequently effects physical and psychological well being. The aim of the present study was to determine the impact of psychological status on health related quality of life in patients with RA and also to assess which quality of life (QoL) instrument - disease specific and generic - is more prone to this effect.
METHODS: A total of 421 patients with RA recruited from joint database of five tertiary centers. Depression and anxiety risks were assessed by the Hospital Anxiety and Depression Scale (HADS); and quality of life assessed by Rheumatoid Arthritis Quality of Life (RAQoL), Nottingham Health Profile (NHP) and The Short Form 36 (SF 36) questionnaire.
RESULTS: Patients with higher risk for depression or anxiety had poorer quality of life compared to the patients without risk for depression or anxiety. Depression and anxiety scores significantly correlated with quality of life questionnaires. There was significant association between anxiety and depression with worsening in both disease specific and generic health related quality of life. However, RAQoL showed more association with depression and anxiety levels.
CONCLUSION: Higher depression and anxiety risks showed increased deterioration in quality of life. Compared to generic QoL scales, RAQoL scale, a disease specific QoL instrument, is much more influenced by depression and anxiety.

Entities:  

Mesh:

Year:  2011        PMID: 21558614     DOI: 10.3233/BMR-2011-0281

Source DB:  PubMed          Journal:  J Back Musculoskelet Rehabil        ISSN: 1053-8127            Impact factor:   1.398


  6 in total

1.  The Relationship Between Anxiety, Depression, Suicidal Ideation and Quality of Life in Patients with Rheumatoid Arthritis.

Authors:  Aslı Beşirli; Jülide Öncü Alptekin; Derya Kaymak; Ömer Akil Özer
Journal:  Psychiatr Q       Date:  2020-03

2.  Lay Perspectives of Quality of Life in Rheumatoid Arthritis Patients: The Relevance of Autonomy and Psychological Distress.

Authors:  Isabel Santos; Natália Duarte; Oscar Ribeiro; Pedro Cantista; Carlos Vasconcelos
Journal:  Community Ment Health J       Date:  2019-03-29

3.  Health-Related Quality of Life in Patients with Arthritis: A Cross-Sectional Survey among Middle-Aged Adults in Chongqing, China.

Authors:  Yunshuang Rao; Xianglong Xu; Dengyuan Liu; Cesar Reis; Ian M Newman; Liqiang Qin; Manoj Sharma; Jun Shen; Yong Zhao
Journal:  Int J Environ Res Public Health       Date:  2018-04-16       Impact factor: 3.390

4.  Comparison of health-related quality of life in patients with rheumatoid arthritis during conventional or conventional plus biological therapy in Poland.

Authors:  Ewelina Bąk; Czesław Marcisz; Adriana Borodzicz; Danuta Sternal; Sylwia Krzemińska
Journal:  Patient Prefer Adherence       Date:  2019-01-24       Impact factor: 2.711

5.  The relationship between traits optimism and anxiety and health-related quality of life in patients hospitalized for chronic diseases: data from the SATISQOL study.

Authors:  Sabrina Kepka; Cédric Baumann; Amélie Anota; Gaelle Buron; Elisabeth Spitz; Pascal Auquier; Francis Guillemin; Mariette Mercier
Journal:  Health Qual Life Outcomes       Date:  2013-08-05       Impact factor: 3.186

6.  Tailored, Therapist-Guided Internet-Based Cognitive Behavioral Therapy Compared to Care as Usual for Patients With Rheumatoid Arthritis: Economic Evaluation of a Randomized Controlled Trial.

Authors:  Maaike Ferwerda; Sylvia van Beugen; Henriët van Middendorp; Henk Visser; Harald Vonkeman; Marjonne Creemers; Piet van Riel; Wietske Kievit; Andrea Evers
Journal:  J Med Internet Res       Date:  2018-10-11       Impact factor: 5.428

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.